Cleanroom Documentation Systems

Article

Pharmaceutical Technology Europe

Introducing VAI’s Cleanroom Documentation Systems, the Core2Print, Core2Write, and CleanPrint 10 that address the problem of documentation materials that shed fibers or particulates in aseptic GMP operations.

 

VAI’s Cleanroom Documentation Systems have been developed to address documentation materials that shed fibers or particulates in aseptic GMP operation.

 

Core2Write is a product line developed by VAI that revolutionizes documentation methods, with custom logbooks, labels, forms, and tags printed on CleanPrint 10 synthetic paper. Core2Write products are designed and packaged according to customer specifications, and incorporate customer specific documentation requirements.  To mitigate the risk of losing critical documentation, Core2Write products have the option of adding a barcode or patented RFID technology.

 

CleanPrint10 is a patented synthetic substrate that is used as the base for all Core2Write products and used as the medium in the Core2Print. CleanPrint 10 is durable, and comprised of adhesive bonds that are as much as 10 times more durable than other synthetic substrates. CleanPrint 10 is pliable, resistant to abrasion, chemicals, and ink smearing. In addition, this substrate is cellulose free and extremely low in particle shedding.

 

The Core2Print, the cleanroom printer, is constructed of a 316L Stainless Steel cabinet and Lexan windows for durability. The cabinet is also equipped with HEPA filtration, with positive pressure to the cabinet to be equally filtered to the controlled environment. The CP10 printer is housed in the cabinet and wirelessly prints onto VAI’s pre-sterilized CleanPrint 10.

 

Company name:  Veltek Associates, Inc.       

Website: www.sterile.com

E-mail: vai@sterile.com

Recent Videos
Tore Bergsteiner from MAIN5 details his predictions for how the mega trends will shape the bio/pharma industry in 2025 and beyond.
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Related Content